Technical Description
This technology is a hydrogel-based formulation for wound management offering biocompatible, sustained, and targeted release of therapeutic agents to support all four phases of wound healing
Problems Addressed
- Lacks Full-phase Healing
- Inefficient Drug Release
- Lacks Inflammation Control
- Lacks Multifunctional Delivery
- Inefficient Healing Support
- Lacks Sustained Action
- Lacks Targeted Formulation
- Inefficient Chronic Wound Care
Tech Features
- Efficient Multi Phase Targeting
- Enhanced Sustained Delivery
- Efficient Inflammation Control
- Enhanced Diabetic Wound Repair
- Cost Effective Formulation
- Biocompatible Hydrogel System
Target Audience
- Wound Care Product Companies
- Biomedical Device Manufacturers
- Hospitals And Clinical Care Centers
- Pharmaceutical And Biotech Firms
- Academic & Research Institutions
Tech ID: P24-1457 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
